Overview

Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects.

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The epoetin is a glycoprotein and endogenous hormone, which is primarily synthesized by specific epithelial cells lining the kidney peritubular capillaries, and regulates continuous formation of red blood cells. This is a pharmacokinetics and pharmacodynamics study, in which each subject will receive the investigational product in different periods, as randomisation (Teste or Comparator). The evaluation of the profile included serum dosage of medications and reticulocyte count in peripheral blood.
Phase:
Phase 1
Details
Lead Sponsor:
Azidus Brasil
Collaborator:
Blau Farmaceutica S.A.
Treatments:
Epoetin Alfa